By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Matinas BioPharma 

915 Klosterman Road East

Tarpon Springs  Florida  34689  U.S.A.
Phone: 1-908-443-1860 Fax: n/a


Company News
Matinas BioPharma To Present At The 8th Annual LD Micro Main Event On December 3, 2015 11/19/2015 11:21:44 AM
Matinas BioPharma Reports 2015 Third Quarter Financial Results And Provides Business Update 11/10/2015 8:18:58 AM
Matinas BioPharma Receives Notice Of Allowance Of U.S. Patent For Encochleated siRNA 10/26/2015 12:25:23 PM
Matinas BioPharma Selected To Present At Cavendish Global Health Impact Forum 10/22/2015 8:23:27 AM
Matinas BioPharma Presents Pre-Clinical Data Showing Anti-Bacterial Activity Of MAT2501 - Encochleated Amikacin - Against Mycobacterium Avium Lung Infections At ICAAC/ICC 2015 9/21/2015 8:04:01 AM
Matinas BioPharma's MAT2203 -- Encochleated Formulation Of Amphotericin B -- Shows Potential To Target And Penetrate Tissue Infected With Invasive Candidiasis In Data Presented At ICAAC/ICC 2015 9/21/2015 7:20:22 AM
Matinas BioPharma Appoints International Expert And Thought Leader On Invasive Fungal Infections Peter G. Pappas, M.D., FACP, To Scientific Advisory Board 9/17/2015 11:43:55 AM
Matinas BioPharma To Present At The 17th Annual Rodman & Renshaw Global Investment Conference On September 9, 2015 9/2/2015 8:14:27 AM
Matinas BioPharma Appoints Cochleate Technology Pioneer Raphael J. Mannino, Ph.D., As Senior Vice President And Chief Technology Officer 9/1/2015 7:22:08 AM
Matinas BioPharma's Lead Antifungal Product Candidate MAT2203 Granted QIDP And Fast Track Designations By FDA 8/18/2015 8:15:22 AM